Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-199b-5p AADAC -0.45 0.25461 -1.53 0 miRanda -0.16 4.0E-5 NA
2 hsa-miR-199b-5p AADAT -0.45 0.25461 -3.7 0 miRanda -0.15 0.00013 NA
3 hsa-miR-301a-3p ABCA1 0.84 0 -1.1 0 miRNATAP -0.13 0.00125 NA
4 hsa-miR-301a-3p ABCB7 0.84 0 -0.34 4.0E-5 MirTarget; miRNATAP -0.11 0 NA
5 hsa-let-7c-5p ABCB9 -1.71 0 1.01 0 MirTarget -0.27 0 NA
6 hsa-miR-195-5p ABCB9 -1.86 0 1.01 0 mirMAP -0.1 0.01229 NA
7 hsa-let-7c-5p ABCC10 -1.71 0 1.42 0 MirTarget -0.3 0 NA
8 hsa-miR-101-3p ABCC5 -1.48 0 1.23 0 MirTarget; miRNATAP -0.47 0 NA
9 hsa-miR-195-5p ABCC5 -1.86 0 1.23 0 MirTarget; miRNATAP -0.17 0 NA
10 hsa-miR-199b-5p ABCC6 -0.45 0.25461 -0.92 0 miRanda -0.1 1.0E-5 NA
11 hsa-miR-199a-5p ABCC6P2 -1.99 0 0.58 0.00027 miRanda -0.13 0 NA
12 hsa-miR-199b-5p ABCG2 -0.45 0.25461 -1.71 0 miRanda -0.19 0 NA
13 hsa-miR-301a-3p ABHD2 0.84 0 -1.2 0 mirMAP -0.38 0 NA
14 hsa-miR-199b-5p ABHD6 -0.45 0.25461 -1.31 0 miRanda -0.12 0 NA
15 hsa-miR-101-3p ABI2 -1.48 0 0.14 0.17339 miRNATAP -0.24 0 NA
16 hsa-miR-301a-3p ABTB2 0.84 0 -0.43 0.0031 mirMAP -0.21 0 NA
17 hsa-miR-101-3p ACBD3 -1.48 0 0.28 0.00131 miRNATAP -0.13 2.0E-5 NA
18 hsa-miR-301a-3p ACBD5 0.84 0 -0.75 0 MirTarget; miRNATAP -0.25 0 NA
19 hsa-miR-199b-5p ACOT13 -0.45 0.25461 -0.49 3.0E-5 miRanda -0.14 0 NA
20 hsa-miR-301a-3p ACSL1 0.84 0 -2.33 0 MirTarget; miRNATAP -0.56 0 NA
21 hsa-miR-101-3p ACSL4 -1.48 0 2.07 0 miRNATAP -0.89 0 NA
22 hsa-miR-195-5p ACSL4 -1.86 0 2.07 0 MirTarget; miRNATAP -0.44 0 NA
23 hsa-miR-199a-5p ACTN2 -1.99 0 1.96 2.0E-5 miRanda -0.23 0.00264 NA
24 hsa-miR-199b-5p ACTN2 -0.45 0.25461 1.96 2.0E-5 miRanda -0.19 0.00143 NA
25 hsa-miR-101-3p ADAMTS10 -1.48 0 0.73 0.00187 miRNATAP -0.28 0.00079 NA
26 hsa-miR-199a-5p ADCK5 -1.99 0 0.84 0 miRanda -0.11 0 NA
27 hsa-miR-301a-3p ADCY1 0.84 0 -2.7 0 MirTarget; miRNATAP -0.4 0.00018 NA
28 hsa-miR-101-3p ADCY6 -1.48 0 1.25 0 miRNATAP -0.34 0 NA
29 hsa-miR-199b-5p ADH4 -0.45 0.25461 -4.41 0 miRanda -0.19 0.00683 NA
30 hsa-miR-199a-5p ADH6 -1.99 0 -2.17 0 miRanda -0.11 0.02462 NA
31 hsa-miR-199b-5p ADH6 -0.45 0.25461 -2.17 0 miRanda -0.21 0 NA
32 hsa-miR-199b-5p ADHFE1 -0.45 0.25461 -1.33 0 miRanda -0.18 0 NA
33 hsa-miR-301a-3p AFF1 0.84 0 -0.71 0 MirTarget -0.16 0 NA
34 hsa-miR-101-3p AGAP1 -1.48 0 0.52 0 MirTarget -0.21 0 NA
35 hsa-miR-199a-5p AGBL5 -1.99 0 0.72 0 miRanda -0.13 0 NA
36 hsa-miR-101-3p AGFG1 -1.48 0 0.23 0.00166 MirTarget -0.12 0 NA
37 hsa-miR-199b-5p AGXT2 -0.45 0.25461 -2.89 0 miRanda -0.16 0.002 NA
38 hsa-miR-199b-5p AKAP6 -0.45 0.25461 -0.97 0 miRanda -0.11 0 NA
39 hsa-miR-199a-5p AKR1C2 -1.99 0 0.25 0.39842 miRanda -0.19 8.0E-5 NA
40 hsa-miR-199b-5p AKR1C2 -0.45 0.25461 0.25 0.39842 miRanda -0.16 2.0E-5 NA
41 hsa-miR-199a-5p ALDH1L1 -1.99 0 -1.8 0 miRanda -0.21 0.00084 NA
42 hsa-miR-199b-5p ALDH1L1 -0.45 0.25461 -1.8 0 miRanda -0.33 0 NA
43 hsa-miR-301a-3p ALDH5A1 0.84 0 -1.1 0 mirMAP -0.41 0 NA
44 hsa-miR-199a-5p ALKBH2 -1.99 0 0.58 2.0E-5 miRanda -0.14 0 NA
45 hsa-miR-199b-5p ALKBH2 -0.45 0.25461 0.58 2.0E-5 miRanda -0.11 0 NA
46 hsa-miR-101-3p AMMECR1 -1.48 0 0.07 0.45093 miRNATAP -0.11 0.00172 NA
47 hsa-miR-301a-3p AMOTL1 0.84 0 -0.53 0.02603 mirMAP -0.16 0.01497 NA
48 hsa-miR-199a-5p ANKAR -1.99 0 0.96 0 miRanda -0.12 0 NA
49 hsa-miR-195-5p ANKRD13D -1.86 0 0.79 0 MirTarget -0.11 0.00036 NA
50 hsa-miR-199a-5p ANKRD26P1 -1.99 0 0.43 0.21485 miRanda -0.16 0.00457 NA
51 hsa-miR-101-3p ANKRD27 -1.48 0 0.9 0 mirMAP -0.33 0 NA
52 hsa-let-7c-5p ANKRD49 -1.71 0 0.4 0 MirTarget -0.1 0 NA
53 hsa-miR-101-3p ANKRD52 -1.48 0 1.46 0 miRNATAP -0.5 0 NA
54 hsa-miR-199a-3p ANKRD52 -2.33 0 1.46 0 PITA; miRNATAP -0.11 0 NA
55 hsa-miR-101-3p ANKZF1 -1.48 0 0.85 0 MirTarget -0.19 0 NA
56 hsa-miR-301a-3p AP1G1 0.84 0 -0.48 0 miRNATAP -0.19 0 NA
57 hsa-miR-101-3p AP1S3 -1.48 0 0.35 0.01747 miRNAWalker2 validate -0.28 0 NA
58 hsa-miR-199a-3p AP3B1 -2.33 0 0.63 0 PITA -0.1 0 NA
59 hsa-miR-301a-3p AP3S2 0.84 0 -0.33 4.0E-5 mirMAP -0.17 0 NA
60 hsa-miR-301a-3p APBB2 0.84 0 -0.24 0.03085 mirMAP -0.13 1.0E-5 NA
61 hsa-miR-106b-5p APC 0.65 0 -0.18 0.06792 miRNAWalker2 validate; miRTarBase -0.15 0.00024 23087084 miR 106b downregulates adenomatous polyposis coli and promotes cell proliferation in human hepatocellular carcinoma; Moreover we demonstrated that miR-106b downregulates APC expression by directly targeting the 3'-untranslated region of APC messenger RNA; Taken together our results suggest that miR-106b plays an important role in promoting the proliferation of human hepatoma cells and presents a novel mechanism of micro RNA-mediated direct suppression of APC expression in cancer cells
62 hsa-miR-21-5p APC 1.51 0 -0.18 0.06792 miRNAWalker2 validate -0.17 0 23773491; 24832083 The prognostic significance of APC gene mutation and miR 21 expression in advanced stage colorectal cancer; The aim of this study was to analyse the association of APC gene mutation and miR-21 expression with clinical outcome in CRC patients; APC gene mutation and expression of APC and miR-21 were analysed by direct DNA sequencing and real-time reverse transcription polymerase chain reaction; APC gene expression was low in CRC and negatively correlated with miR-21 expression and gene mutation; In Taiwan downregulation of the APC gene in CRC correlated with gene mutation and miR-21 upregulation; APC mutation and miR-21 expression could be used to predict the clinical outcome of CRC especially in patients with advanced disease;MicroRNA 21 promotes tumour malignancy via increased nuclear translocation of β catenin and predicts poor outcome in APC mutated but not in APC wild type colorectal cancer; However in our preliminary data the prognostic value of miR-21 levels was observed only in adenomatous polyposis coli APC-mutated tumours not in APC-wild-type tumours; We enrolled 165 colorectal tumour to determine APC mutation miR-21 levels and nuclear β-catenin expression by direct sequencing real-time PCR and immunohistochemistry
63 hsa-let-7a-5p APC2 -0.33 0.00046 1.72 0 TargetScan -0.3 0.00538 NA
64 hsa-miR-125a-5p APC2 -0.91 0 1.72 0 mirMAP -0.2 0.0003 NA
65 hsa-miR-125b-5p APC2 -1.36 0 1.72 0 mirMAP -0.16 0.01164 NA
66 hsa-miR-185-3p APC2 -0.27 0.0854 1.72 0 MirTarget -0.13 0.04272 NA
67 hsa-miR-194-3p APC2 -0.77 3.0E-5 1.72 0 mirMAP -0.17 0.00111 NA
68 hsa-miR-199a-5p APC2 -1.99 0 1.72 0 mirMAP -0.1 0.00178 NA
69 hsa-miR-20a-3p APC2 -0.32 0.04679 1.72 0 mirMAP -0.25 7.0E-5 NA
70 hsa-miR-2355-5p APC2 -0.23 0.15791 1.72 0 mirMAP -0.14 0.01613 NA
71 hsa-miR-23b-5p APC2 -1.05 0 1.72 0 mirMAP -0.22 0.0013 NA
72 hsa-miR-28-5p APC2 -0.43 0 1.72 0 mirMAP -0.3 0.00527 NA
73 hsa-miR-340-3p APC2 -0.33 0.0033 1.72 0 mirMAP -0.22 0.01183 NA
74 hsa-miR-505-5p APC2 -0.77 1.0E-5 1.72 0 mirMAP -0.15 0.00924 NA
75 hsa-miR-195-5p APLN -1.86 0 3.69 0 MirTarget; miRNATAP -0.63 0 NA
76 hsa-miR-199b-5p APOC1 -0.45 0.25461 -0.97 6.0E-5 miRanda -0.16 0 NA
77 hsa-miR-199b-5p AQP11 -0.45 0.25461 -0.63 0.00064 miRNATAP -0.13 0 NA
78 hsa-miR-301a-3p AR 0.84 0 -2.66 0 mirMAP; miRNATAP -1.06 0 25940439 Mechanism dissection revealed infiltrating pre-adipocytes might function through down-regulation of the androgen receptor AR via modulation of miR-301a and then increase PCa cell invasion via induction of TGF-β1/Smad/MMP9 signals
79 hsa-miR-195-5p ARFGAP1 -1.86 0 0.64 0 mirMAP -0.15 0 NA
80 hsa-miR-301a-3p ARFIP1 0.84 0 -0.21 0.00812 miRNATAP -0.12 0 NA
81 hsa-miR-301a-3p ARHGEF12 0.84 0 -0.86 0 MirTarget; miRNATAP -0.23 0 NA
82 hsa-miR-101-3p ARHGEF3 -1.48 0 0.51 0.00381 MirTarget -0.41 0 NA
83 hsa-miR-195-5p ARL2 -1.86 0 0.82 0 MirTarget; miRNATAP -0.15 1.0E-5 NA
84 hsa-miR-301a-3p ARL6IP1 0.84 0 -0.85 0 MirTarget -0.14 0 NA
85 hsa-miR-301a-3p ARMC5 0.84 0 -0.65 1.0E-5 mirMAP -0.27 0 NA
86 hsa-miR-101-3p ARNTL2 -1.48 0 0.02 0.94112 MirTarget -0.42 0.0001 NA
87 hsa-miR-301a-3p ARRDC3 0.84 0 -0.7 0 miRNATAP -0.11 0.00797 NA
88 hsa-miR-301a-3p ART4 0.84 0 -1.74 0 mirMAP -0.42 0 NA
89 hsa-miR-101-3p ASAP1 -1.48 0 0.6 1.0E-5 MirTarget; miRNATAP -0.42 0 NA
90 hsa-miR-199a-5p ASB4 -1.99 0 -0.62 0.06683 miRanda -0.17 0.0018 NA
91 hsa-miR-199b-5p ASB4 -0.45 0.25461 -0.62 0.06683 miRanda -0.22 0 NA
92 hsa-miR-301a-3p ASPA 0.84 0 -2.88 0 mirMAP -0.46 0 NA
93 hsa-miR-301a-3p ASXL2 0.84 0 -0.29 0.18051 MirTarget; miRNATAP -0.15 0.01157 NA
94 hsa-miR-301a-3p ASXL3 0.84 0 -2.69 0 mirMAP -0.64 0 NA
95 hsa-miR-301a-3p ATF6 0.84 0 -0.02 0.87055 mirMAP -0.15 0 NA
96 hsa-miR-101-3p ATG4D -1.48 0 0.24 0.03588 miRTarBase -0.13 0.00104 NA
97 hsa-miR-199a-5p ATOX1 -1.99 0 0.43 0.00496 mirMAP -0.11 0 NA
98 hsa-miR-199b-5p ATOX1 -0.45 0.25461 0.43 0.00496 mirMAP -0.11 0 NA
99 hsa-miR-101-3p ATP1B1 -1.48 0 0.44 0.00298 miRNATAP -0.21 7.0E-5 NA
100 hsa-miR-101-3p ATP2B1 -1.48 0 -0.16 0.1608 miRNATAP -0.12 0.00303 NA
101 hsa-miR-101-3p ATP5G2 -1.48 0 0.3 0.00093 miRNATAP -0.15 0 NA
102 hsa-miR-301a-3p ATXN7L1 0.84 0 -0.24 0.06065 miRNATAP -0.27 0 NA
103 hsa-miR-195-5p ATXN7L2 -1.86 0 1.07 0 MirTarget; miRNATAP -0.21 0 NA
104 hsa-miR-195-5p ATXN7L3 -1.86 0 0.7 0 MirTarget; miRNATAP -0.16 0 NA
105 hsa-miR-195-5p AVL9 -1.86 0 0.36 0.00032 MirTarget; miRNATAP -0.13 0 NA
106 hsa-miR-320a AXIN1 0.33 0.02214 0.3 0.00968 miRNAWalker2 validate -0.1 0.00946 NA
107 hsa-let-7b-3p AXIN2 -1.22 0 0.11 0.75298 miRNATAP -0.27 0.0205 NA
108 hsa-let-7g-3p AXIN2 -1.14 0 0.11 0.75298 MirTarget -0.33 0.01126 NA
109 hsa-miR-15b-5p AXIN2 0.23 0.08248 0.11 0.75298 miRTarBase; MirTarget; miRNATAP -0.45 0.00081 NA
110 hsa-miR-16-2-3p AXIN2 -0.03 0.80516 0.11 0.75298 mirMAP -0.64 0 NA
111 hsa-miR-16-5p AXIN2 -0.4 0.0001 0.11 0.75298 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.49 0.00421 NA
112 hsa-miR-195-3p AXIN2 -1.09 0 0.11 0.75298 mirMAP -0.31 0.00083 NA
113 hsa-miR-195-5p AXIN2 -1.86 0 0.11 0.75298 MirTarget; miRNATAP -0.25 0.00506 NA
114 hsa-miR-26b-3p AXIN2 -1.26 0 0.11 0.75298 MirTarget -0.59 3.0E-5 NA
115 hsa-miR-326 AXIN2 -1.88 0 0.11 0.75298 miRanda -0.36 2.0E-5 NA
116 hsa-miR-338-5p AXIN2 -0.22 0.25239 0.11 0.75298 miRNATAP -0.34 0.00017 NA
117 hsa-miR-424-5p AXIN2 -2.63 0 0.11 0.75298 MirTarget; miRNATAP -0.19 0.03018 NA
118 hsa-miR-497-5p AXIN2 -1.41 0 0.11 0.75298 MirTarget; miRNATAP -0.29 0.00329 NA
119 hsa-miR-616-3p AXIN2 -0.7 2.0E-5 0.11 0.75298 MirTarget -0.42 8.0E-5 NA
120 hsa-miR-101-3p B3GALNT2 -1.48 0 0.86 0 MirTarget -0.25 0 NA
121 hsa-miR-101-3p B3GNT3 -1.48 0 0.22 0.62814 MirTarget -1.39 0 NA
122 hsa-miR-199a-5p BAAT -1.99 0 -1.22 1.0E-5 PITA; miRanda -0.12 0.00643 NA
123 hsa-miR-199b-5p BAAT -0.45 0.25461 -1.22 1.0E-5 PITA; miRanda -0.19 0 NA
124 hsa-miR-301a-3p BACH2 0.84 0 -1.99 0 mirMAP; miRNATAP -0.29 4.0E-5 NA
125 hsa-miR-101-3p BAZ2A -1.48 0 0.46 0 MirTarget; miRNATAP -0.19 0 NA
126 hsa-miR-101-3p BBC3 -1.48 0 0.8 0 miRNATAP -0.32 0 NA
127 hsa-miR-101-3p BCL9 -1.48 0 1.18 0 miRNAWalker2 validate; MirTarget; miRNATAP -0.42 0 NA
128 hsa-miR-101-3p BEGAIN -1.48 0 -0.42 0.21738 MirTarget -0.25 0.03932 NA
129 hsa-miR-199b-5p BHMT -0.45 0.25461 -3.29 0 miRanda -0.35 0 NA
130 hsa-miR-101-3p BIRC5 -1.48 0 4.5 0 miRNAWalker2 validate -1.33 0 NA
131 hsa-miR-199b-5p BLCAP -0.45 0.25461 -0.41 0.00021 PITA; miRanda; miRNATAP -0.1 0 NA
132 hsa-miR-301a-3p BLCAP 0.84 0 -0.41 0.00021 MirTarget; miRNATAP -0.17 0 NA
133 hsa-miR-301a-3p BMP6 0.84 0 -1.04 0 MirTarget -0.14 0.01206 NA
134 hsa-miR-301a-3p BMPR2 0.84 0 -0.74 0 MirTarget; miRNATAP -0.11 0.00019 NA
135 hsa-miR-199a-5p BRCA1 -1.99 0 0.89 0 miRanda -0.14 0 NA
136 hsa-miR-195-5p BRPF3 -1.86 0 0.35 0.00299 miRNATAP -0.15 0 NA
137 hsa-miR-195-5p BSG -1.86 0 0.9 0 mirMAP -0.14 0 NA
138 hsa-miR-199a-5p BSN -1.99 0 0.94 2.0E-5 miRanda -0.14 9.0E-5 NA
139 hsa-miR-101-3p BTBD3 -1.48 0 0.3 0.00861 miRNATAP -0.16 0.0001 NA
140 hsa-miR-101-3p BTG2 -1.48 0 -0.63 0.00028 miRNAWalker2 validate -0.14 0.0208 NA
141 hsa-miR-199a-5p BTNL9 -1.99 0 0.27 0.25012 miRanda -0.11 0.00436 NA
142 hsa-miR-199b-5p BTNL9 -0.45 0.25461 0.27 0.25012 miRanda -0.19 0 NA
143 hsa-miR-15b-5p BTRC 0.23 0.08248 -0 0.97671 MirTarget; miRNATAP -0.12 0 NA
144 hsa-miR-16-5p BTRC -0.4 0.0001 -0 0.97671 miRNAWalker2 validate; MirTarget; miRNATAP -0.17 0 NA
145 hsa-miR-193a-3p BTRC -0.12 0.30939 -0 0.97671 MirTarget; miRanda -0.15 0 NA
146 hsa-miR-193b-3p BTRC -0.17 0.27202 -0 0.97671 miRNAWalker2 validate -0.16 0 NA
147 hsa-miR-361-3p BTRC 0.28 0.00549 -0 0.97671 MirTarget; PITA; miRNATAP -0.1 0.00495 NA
148 hsa-miR-497-5p BTRC -1.41 0 -0 0.97671 MirTarget; miRNATAP -0.11 0 NA
149 hsa-miR-505-3p BTRC -1.2 0 -0 0.97671 MirTarget -0.13 0 NA
150 hsa-miR-199a-5p BUB1 -1.99 0 4.05 0 miRanda -0.29 0 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 WNT SIGNALING PATHWAY 97 351 1.962e-42 9.13e-39
2 CANONICAL WNT SIGNALING PATHWAY 42 95 3.246e-28 7.552e-25
3 REGULATION OF WNT SIGNALING PATHWAY 73 310 2.745e-27 4.257e-24
4 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 50 197 1.429e-20 1.662e-17
5 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 54 236 7.204e-20 6.704e-17
6 NON CANONICAL WNT SIGNALING PATHWAY 41 140 1.4e-19 1.086e-16
7 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 127 1021 5.211e-19 3.464e-16
8 POSITIVE REGULATION OF GENE EXPRESSION 178 1733 1.635e-17 9.509e-15
9 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 183 1805 1.981e-17 1.024e-14
10 REGULATION OF CELL DIFFERENTIATION 158 1492 9.607e-17 4.47e-14
11 BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY 16 22 2.694e-16 9.436e-14
12 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 170 1672 2.66e-16 9.436e-14
13 NEUROGENESIS 150 1402 2.699e-16 9.436e-14
14 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 40 162 2.839e-16 9.436e-14
15 REGULATION OF CELL CYCLE 114 949 5.224e-16 1.62e-13
16 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 176 1784 1.306e-15 3.799e-13
17 ORGAN MORPHOGENESIS 104 841 1.621e-15 4.438e-13
18 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 156 1517 2.113e-15 5.461e-13
19 INTRACELLULAR SIGNAL TRANSDUCTION 159 1572 4.679e-15 1.113e-12
20 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 116 1004 4.785e-15 1.113e-12
21 REGULATION OF ORGAN MORPHOGENESIS 47 242 1.525e-14 3.379e-12
22 CELL CYCLE 138 1316 2.471e-14 5.226e-12
23 EMBRYO DEVELOPMENT 105 894 3.672e-14 7.428e-12
24 NEGATIVE REGULATION OF GENE EXPRESSION 150 1493 5.524e-14 1.071e-11
25 TISSUE DEVELOPMENT 151 1518 1.015e-13 1.889e-11
26 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 75 554 1.89e-13 3.382e-11
27 TISSUE MORPHOGENESIS 73 533 2.236e-13 3.853e-11
28 REGULATION OF EMBRYONIC DEVELOPMENT 30 114 2.472e-13 4.109e-11
29 REGULATION OF CELL CYCLE PROCESS 75 558 2.737e-13 4.392e-11
30 WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY 18 39 2.946e-13 4.57e-11
31 NEURON DIFFERENTIATION 101 874 3.229e-13 4.847e-11
32 TUBE MORPHOGENESIS 53 323 4.19e-13 6.092e-11
33 MITOTIC CELL CYCLE 92 766 4.344e-13 6.125e-11
34 CELL CYCLE PROCESS 116 1081 7.967e-13 1.09e-10
35 EPITHELIUM DEVELOPMENT 105 945 1.271e-12 1.689e-10
36 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 84 684 1.463e-12 1.891e-10
37 NEGATIVE REGULATION OF CELL COMMUNICATION 123 1192 2.292e-12 2.882e-10
38 CELL DEVELOPMENT 140 1426 2.468e-12 3.023e-10
39 REGULATION OF MITOTIC CELL CYCLE 65 468 2.556e-12 3.05e-10
40 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 135 1360 2.919e-12 3.396e-10
41 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 68 513 7.001e-12 7.945e-10
42 EMBRYONIC MORPHOGENESIS 70 539 8.913e-12 9.874e-10
43 POSITIVE REGULATION OF CELL COMMUNICATION 145 1532 1.48e-11 1.602e-09
44 MORPHOGENESIS OF AN EPITHELIUM 57 400 2.085e-11 2.205e-09
45 CELL PROLIFERATION 80 672 2.478e-11 2.538e-09
46 REGULATION OF CELL GROWTH 56 391 2.564e-11 2.538e-09
47 REGULATION OF CELL DEVELOPMENT 93 836 2.525e-11 2.538e-09
48 POSITIVE REGULATION OF CELL CYCLE 50 332 4.907e-11 4.659e-09
49 CENTRAL NERVOUS SYSTEM DEVELOPMENT 95 872 4.864e-11 4.659e-09
50 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 140 1492 6.456e-11 6.008e-09
51 TUBE DEVELOPMENT 69 552 7.158e-11 6.484e-09
52 SENSORY ORGAN DEVELOPMENT 64 493 7.246e-11 6.484e-09
53 NEGATIVE REGULATION OF CELL CYCLE PROCESS 38 214 8.35e-11 7.331e-09
54 POSITIVE REGULATION OF MOLECULAR FUNCTION 160 1791 1.016e-10 8.758e-09
55 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 114 1142 1.243e-10 1.052e-08
56 NEGATIVE REGULATION OF CELL GROWTH 33 170 1.296e-10 1.077e-08
57 NEGATIVE REGULATION OF MITOTIC CELL CYCLE 36 199 1.523e-10 1.235e-08
58 REGULATION OF CELL CYCLE PHASE TRANSITION 48 321 1.539e-10 1.235e-08
59 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 84 750 1.752e-10 1.382e-08
60 REGULATION OF ORGANELLE ORGANIZATION 116 1178 1.945e-10 1.508e-08
61 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 49 337 2.679e-10 2.043e-08
62 POSITIVE REGULATION OF CELL DIFFERENTIATION 89 823 3.022e-10 2.268e-08
63 REGULATION OF CELLULAR LOCALIZATION 122 1277 4.232e-10 3.125e-08
64 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 113 1152 4.306e-10 3.13e-08
65 REGULATION OF CELLULAR PROTEIN LOCALIZATION 67 552 4.816e-10 3.395e-08
66 NEGATIVE REGULATION OF CELL CYCLE 57 433 4.745e-10 3.395e-08
67 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 82 740 4.898e-10 3.402e-08
68 REGULATION OF NEURON DIFFERENTIATION 67 554 5.614e-10 3.841e-08
69 POSITIVE REGULATION OF WNT SIGNALING PATHWAY 30 152 5.869e-10 3.958e-08
70 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 102 1008 6.095e-10 4.051e-08
71 POSITIVE REGULATION OF RESPONSE TO STIMULUS 166 1929 7.437e-10 4.874e-08
72 REGULATION OF OSTEOBLAST DIFFERENTIATION 25 112 1.084e-09 7.002e-08
73 DORSAL VENTRAL AXIS SPECIFICATION 11 20 1.194e-09 7.612e-08
74 REGULATION OF PHOSPHORUS METABOLIC PROCESS 144 1618 1.325e-09 8.331e-08
75 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 168 1977 1.476e-09 9.157e-08
76 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 97 957 1.52e-09 9.249e-08
77 NEGATIVE REGULATION OF GROWTH 38 236 1.535e-09 9.249e-08
78 REGULATION OF PROTEIN MODIFICATION PROCESS 150 1710 1.551e-09 9.249e-08
79 POSITIVE REGULATION OF CELL CYCLE PROCESS 39 247 1.671e-09 9.842e-08
80 REGULATION OF OSSIFICATION 32 178 1.864e-09 1.084e-07
81 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 85 801 1.934e-09 1.111e-07
82 REGULATION OF PROTEIN LOCALIZATION 96 950 2.171e-09 1.232e-07
83 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 102 1036 2.693e-09 1.49e-07
84 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 102 1036 2.693e-09 1.49e-07
85 REGULATION OF BINDING 42 283 2.722e-09 1.49e-07
86 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 109 1135 2.973e-09 1.609e-07
87 REGULATION OF CELL MORPHOGENESIS 65 552 3.021e-09 1.616e-07
88 REGULATION OF TRANSPORT 155 1804 3.373e-09 1.784e-07
89 REGULATION OF ESTABLISHMENT OF PLANAR POLARITY 24 110 3.785e-09 1.979e-07
90 NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION 28 146 4.293e-09 2.171e-07
91 CARDIOVASCULAR SYSTEM DEVELOPMENT 83 788 4.283e-09 2.171e-07
92 CIRCULATORY SYSTEM DEVELOPMENT 83 788 4.283e-09 2.171e-07
93 REGULATION OF GROWTH 71 633 4.486e-09 2.197e-07
94 ANTERIOR POSTERIOR PATTERN SPECIFICATION 33 194 4.467e-09 2.197e-07
95 CONNECTIVE TISSUE DEVELOPMENT 33 194 4.467e-09 2.197e-07
96 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 78 724 4.724e-09 2.29e-07
97 EMBRYONIC ORGAN MORPHOGENESIS 41 279 5.634e-09 2.703e-07
98 REGULATION OF ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE 9 14 6.062e-09 2.878e-07
99 PATTERN SPECIFICATION PROCESS 53 418 7.273e-09 3.418e-07
100 GLAND DEVELOPMENT 51 395 7.606e-09 3.539e-07
101 SKELETAL SYSTEM DEVELOPMENT 56 455 8.008e-09 3.689e-07
102 REGULATION OF NEURON PROJECTION DEVELOPMENT 52 408 8.457e-09 3.858e-07
103 CELLULAR RESPONSE TO LIPID 56 457 9.369e-09 4.192e-07
104 HEAD DEVELOPMENT 76 709 9.33e-09 4.192e-07
105 REGULATION OF CELL PROJECTION ORGANIZATION 64 558 1.121e-08 4.97e-07
106 RESPONSE TO ABIOTIC STIMULUS 99 1024 1.193e-08 5.237e-07
107 PROTEIN PHOSPHORYLATION 93 944 1.377e-08 5.99e-07
108 CELL CYCLE CHECKPOINT 32 194 1.645e-08 7.089e-07
109 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 142 1656 1.937e-08 8.27e-07
110 TUBE FORMATION 25 129 2.307e-08 9.759e-07
111 NEURON PROJECTION DEVELOPMENT 62 545 2.588e-08 1.085e-06
112 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 25 131 3.181e-08 1.322e-06
113 REGULATION OF CELLULAR RESPONSE TO STRESS 73 691 3.366e-08 1.386e-06
114 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 47 368 4.128e-08 1.67e-06
115 DEVELOPMENTAL GROWTH 44 333 4.113e-08 1.67e-06
116 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 55 465 4.322e-08 1.734e-06
117 RESPONSE TO OXYGEN LEVELS 42 311 4.469e-08 1.747e-06
118 SEGMENTATION 20 89 4.408e-08 1.747e-06
119 REGIONALIZATION 42 311 4.469e-08 1.747e-06
120 REGULATION OF JUN KINASE ACTIVITY 19 81 4.57e-08 1.772e-06
121 HEART DEVELOPMENT 55 466 4.65e-08 1.788e-06
122 CELLULAR RESPONSE TO OXYGEN LEVELS 26 143 4.777e-08 1.822e-06
123 EMBRYONIC ORGAN DEVELOPMENT 50 406 4.98e-08 1.884e-06
124 POSITIVE REGULATION OF CATALYTIC ACTIVITY 131 1518 5.122e-08 1.922e-06
125 REGULATION OF CYTOPLASMIC TRANSPORT 56 481 5.617e-08 2.077e-06
126 REGULATION OF INTRACELLULAR TRANSPORT 67 621 5.624e-08 2.077e-06
127 PHOSPHORYLATION 111 1228 5.694e-08 2.086e-06
128 NEGATIVE REGULATION OF CELL DIFFERENTIATION 66 609 5.977e-08 2.173e-06
129 RESPONSE TO ENDOGENOUS STIMULUS 126 1450 6.45e-08 2.326e-06
130 GROWTH 50 410 6.808e-08 2.437e-06
131 REGULATION OF CELL PROLIFERATION 129 1496 6.865e-08 2.438e-06
132 REGULATION OF CATABOLIC PROCESS 75 731 7.291e-08 2.57e-06
133 CARTILAGE DEVELOPMENT 26 147 8.528e-08 2.961e-06
134 REGULATION OF CELL DEATH 127 1472 8.518e-08 2.961e-06
135 POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 23 119 8.787e-08 3.029e-06
136 CHROMATIN MODIFICATION 60 539 9.446e-08 3.208e-06
137 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 93 983 9.401e-08 3.208e-06
138 CELLULAR COMPONENT MORPHOGENESIS 87 900 9.709e-08 3.274e-06
139 DOPAMINERGIC NEURON DIFFERENTIATION 11 28 1.022e-07 3.421e-06
140 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 33 220 1.044e-07 3.471e-06
141 APPENDAGE DEVELOPMENT 28 169 1.161e-07 3.778e-06
142 LIMB DEVELOPMENT 28 169 1.161e-07 3.778e-06
143 NEURAL TUBE FORMATION 20 94 1.16e-07 3.778e-06
144 UROGENITAL SYSTEM DEVELOPMENT 40 299 1.206e-07 3.898e-06
145 SOMITOGENESIS 16 62 1.265e-07 4.06e-06
146 SOMITE DEVELOPMENT 18 78 1.344e-07 4.285e-06
147 POSITIVE REGULATION OF CATABOLIC PROCESS 48 395 1.386e-07 4.387e-06
148 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 21 104 1.455e-07 4.554e-06
149 REGULATION OF STEM CELL DIFFERENTIATION 22 113 1.458e-07 4.554e-06
150 REPRODUCTIVE SYSTEM DEVELOPMENT 49 408 1.478e-07 4.585e-06
151 POSITIVE REGULATION OF JUN KINASE ACTIVITY 16 63 1.611e-07 4.965e-06
152 REGULATION OF CELL SIZE 28 172 1.698e-07 5.199e-06
153 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 27 162 1.718e-07 5.224e-06
154 MORPHOGENESIS OF EMBRYONIC EPITHELIUM 24 134 2.083e-07 6.294e-06
155 CELL PROJECTION ORGANIZATION 86 902 2.102e-07 6.31e-06
156 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 26 154 2.225e-07 6.637e-06
157 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 150 1848 2.368e-07 6.973e-06
158 NEURON PROJECTION MORPHOGENESIS 48 402 2.356e-07 6.973e-06
159 BETA CATENIN TCF COMPLEX ASSEMBLY 13 43 2.56e-07 7.493e-06
160 NEURON DEVELOPMENT 70 687 2.61e-07 7.549e-06
161 PROTEIN LOCALIZATION 147 1805 2.612e-07 7.549e-06
162 AXIS SPECIFICATION 19 90 2.726e-07 7.829e-06
163 CHROMOSOME ORGANIZATION 93 1009 3.086e-07 8.755e-06
164 FOREBRAIN DEVELOPMENT 44 357 3.081e-07 8.755e-06
165 MORPHOGENESIS OF A BRANCHING STRUCTURE 27 167 3.236e-07 9.126e-06
166 REGULATION OF DEVELOPMENTAL GROWTH 38 289 3.872e-07 1.085e-05
167 INNER EAR MORPHOGENESIS 19 92 3.917e-07 1.091e-05
168 REGULATION OF EXTENT OF CELL GROWTH 20 101 4e-07 1.108e-05
169 MITOTIC CELL CYCLE CHECKPOINT 24 139 4.211e-07 1.159e-05
170 NEURAL TUBE DEVELOPMENT 25 149 4.274e-07 1.17e-05
171 SKELETAL SYSTEM MORPHOGENESIS 30 201 4.379e-07 1.192e-05
172 SECOND MESSENGER MEDIATED SIGNALING 26 160 4.81e-07 1.298e-05
173 CELLULAR RESPONSE TO HORMONE STIMULUS 59 552 4.826e-07 1.298e-05
174 STEM CELL PROLIFERATION 15 60 4.891e-07 1.308e-05
175 POSITIVE REGULATION OF CELL DEATH 63 605 4.941e-07 1.314e-05
176 NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT 10 26 4.983e-07 1.318e-05
177 EAR MORPHOGENESIS 21 112 5.385e-07 1.416e-05
178 CHROMATIN ORGANIZATION 67 663 6.364e-07 1.663e-05
179 POSITIVE REGULATION OF CELL PROLIFERATION 78 814 6.477e-07 1.684e-05
180 REGULATION OF PROTEIN TARGETING 39 307 6.663e-07 1.722e-05
181 NEURON PROJECTION GUIDANCE 30 205 6.728e-07 1.73e-05
182 EAR DEVELOPMENT 29 195 7.321e-07 1.871e-05
183 SENSORY ORGAN MORPHOGENESIS 33 239 7.36e-07 1.871e-05
184 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 35 262 7.588e-07 1.898e-05
185 REGULATION OF EPITHELIAL CELL PROLIFERATION 37 285 7.527e-07 1.898e-05
186 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 45 381 7.576e-07 1.898e-05
187 RESPONSE TO DRUG 49 431 7.686e-07 1.912e-05
188 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 24 144 8.202e-07 2.03e-05
189 CELLULAR RESPONSE TO ACID CHEMICAL 27 175 8.408e-07 2.07e-05
190 CELLULAR RESPONSE TO ALCOHOL 21 115 8.495e-07 2.08e-05
191 GASTRULATION 25 155 9.167e-07 2.233e-05
192 CELL DIVISION 51 460 9.795e-07 2.374e-05
193 REGULATION OF MESENCHYMAL CELL PROLIFERATION 11 34 1.008e-06 2.431e-05
194 CELL CYCLE PHASE TRANSITION 34 255 1.137e-06 2.693e-05
195 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 21 117 1.14e-06 2.693e-05
196 REGULATION OF CHROMOSOME ORGANIZATION 36 278 1.125e-06 2.693e-05
197 REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 8 17 1.13e-06 2.693e-05
198 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 76 799 1.198e-06 2.806e-05
199 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 117 1395 1.212e-06 2.806e-05
200 REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 24 147 1.203e-06 2.806e-05
201 CELLULAR COMPONENT DISASSEMBLY 55 515 1.209e-06 2.806e-05
202 REGULATION OF AXONOGENESIS 26 168 1.258e-06 2.897e-05
203 MESENCHYME DEVELOPMENT 28 190 1.362e-06 3.123e-05
204 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 28 191 1.516e-06 3.423e-05
205 REGULATION OF KINASE ACTIVITY 74 776 1.512e-06 3.423e-05
206 MITOTIC DNA INTEGRITY CHECKPOINT 19 100 1.502e-06 3.423e-05
207 REGULATION OF TRANSFERASE ACTIVITY 86 946 1.544e-06 3.47e-05
208 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 13 50 1.744e-06 3.901e-05
209 MACROMOLECULAR COMPLEX DISASSEMBLY 27 182 1.836e-06 4.088e-05
210 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 21 121 2.01e-06 4.453e-05
211 REGULATION OF PROTEIN IMPORT 27 183 2.045e-06 4.509e-05
212 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 17 84 2.135e-06 4.665e-05
213 POSITIVE REGULATION OF OSSIFICATION 17 84 2.135e-06 4.665e-05
214 RHYTHMIC PROCESS 37 298 2.222e-06 4.83e-05
215 POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS 34 263 2.303e-06 4.983e-05
216 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 31 229 2.417e-06 5.186e-05
217 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 42 360 2.419e-06 5.186e-05
218 CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 30 218 2.487e-06 5.284e-05
219 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 30 218 2.487e-06 5.284e-05
220 NEGATIVE REGULATION OF ORGANELLE ORGANIZATION 44 387 2.787e-06 5.895e-05
221 RESPIRATORY SYSTEM DEVELOPMENT 28 197 2.82e-06 5.937e-05
222 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 14 60 2.863e-06 6e-05
223 PROTEIN COMPLEX SUBUNIT ORGANIZATION 124 1527 2.927e-06 6.108e-05
224 NEGATIVE REGULATION OF CELL DEVELOPMENT 37 303 3.296e-06 6.817e-05
225 CONVERGENT EXTENSION 7 14 3.284e-06 6.817e-05
226 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 42 365 3.443e-06 7.089e-05
227 REGULATION OF FAT CELL DIFFERENTIATION 19 106 3.727e-06 7.627e-05
228 DNA INTEGRITY CHECKPOINT 23 146 3.737e-06 7.627e-05
229 MACROMOLECULAR COMPLEX ASSEMBLY 115 1398 3.803e-06 7.728e-05
230 POSITIVE REGULATION OF KINASE ACTIVITY 51 482 3.84e-06 7.768e-05
231 REGULATION OF PROTEIN CATABOLIC PROCESS 44 393 4.172e-06 8.377e-05
232 REGULATION OF STEM CELL PROLIFERATION 17 88 4.177e-06 8.377e-05
233 STEM CELL DIFFERENTIATION 27 190 4.235e-06 8.458e-05
234 MUSCLE STRUCTURE DEVELOPMENT 47 432 4.342e-06 8.633e-05
235 REGULATION OF AXON GUIDANCE 11 39 4.601e-06 9.102e-05
236 POSITIVE REGULATION OF CELL DEVELOPMENT 50 472 4.616e-06 9.102e-05
237 RESPONSE TO NUTRIENT 27 191 4.683e-06 9.195e-05
238 REGULATION OF MUSCLE ADAPTATION 14 63 5.301e-06 0.0001036
239 REGULATION OF CYTOSKELETON ORGANIZATION 52 502 5.703e-06 0.0001104
240 CELL FATE COMMITMENT 30 227 5.716e-06 0.0001104
241 POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 25 171 5.705e-06 0.0001104
242 POSITIVE REGULATION OF TRANSPORT 83 936 6.157e-06 0.0001179
243 POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT 10 33 6.136e-06 0.0001179
244 RESPONSE TO HORMONE 80 893 6.251e-06 0.0001192
245 EPITHELIAL TO MESENCHYMAL TRANSITION 13 56 6.861e-06 0.0001303
246 PROTEIN COMPLEX BIOGENESIS 96 1132 7.455e-06 0.0001386
247 REGULATION OF MUSCLE CELL DIFFERENTIATION 23 152 7.469e-06 0.0001386
248 REGULATION OF CATENIN IMPORT INTO NUCLEUS 9 27 7.478e-06 0.0001386
249 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 9 27 7.478e-06 0.0001386
250 AXIS ELONGATION 9 27 7.478e-06 0.0001386
251 PROTEIN COMPLEX ASSEMBLY 96 1132 7.455e-06 0.0001386
252 RESPONSE TO EXTRACELLULAR STIMULUS 47 441 7.547e-06 0.0001393
253 CELLULAR RESPONSE TO RETINOIC ACID 14 65 7.815e-06 0.0001427
254 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 60 616 7.819e-06 0.0001427
255 COCHLEA MORPHOGENESIS 8 21 7.784e-06 0.0001427
256 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 10 34 8.272e-06 0.0001504
257 VASCULATURE DEVELOPMENT 49 469 8.37e-06 0.0001515
258 REGULATION OF DNA BINDING 17 93 9.1e-06 0.0001641
259 MESODERM MORPHOGENESIS 14 66 9.429e-06 0.0001694
260 CELLULAR RESPONSE TO STRESS 124 1565 9.649e-06 0.0001727
261 RESPONSE TO OXYGEN CONTAINING COMPOUND 112 1381 9.754e-06 0.0001739
262 MESENCHYMAL CELL DIFFERENTIATION 21 134 1.059e-05 0.0001881
263 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 34 282 1.071e-05 0.0001895
264 RESPONSE TO ACID CHEMICAL 37 319 1.082e-05 0.0001906
265 REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 16 85 1.126e-05 0.0001974
266 POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 41 370 1.128e-05 0.0001974
267 REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS 14 67 1.133e-05 0.0001975
268 HEART MORPHOGENESIS 28 212 1.172e-05 0.0002035
269 REGULATION OF CELL CYCLE G2 M PHASE TRANSITION 13 59 1.263e-05 0.0002185
270 OSTEOBLAST DIFFERENTIATION 20 126 1.406e-05 0.0002414
271 RESPONSE TO UV 20 126 1.406e-05 0.0002414
272 CELLULAR RESPONSE TO NITROGEN COMPOUND 51 505 1.411e-05 0.0002414
273 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 56 573 1.419e-05 0.0002418
274 REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 13 60 1.533e-05 0.0002604
275 REGULATION OF CELLULAR COMPONENT MOVEMENT 70 771 1.544e-05 0.0002613
276 REGULATION OF JNK CASCADE 23 159 1.59e-05 0.000268
277 MAMMARY GLAND DEVELOPMENT 19 117 1.641e-05 0.0002757
278 RESPONSE TO NITROGEN COMPOUND 76 859 1.651e-05 0.0002763
279 EPITHELIAL CELL DIFFERENTIATION 50 495 1.7e-05 0.0002835
280 CELLULAR RESPONSE TO EXTERNAL STIMULUS 32 264 1.73e-05 0.0002874
281 BLOOD VESSEL MORPHOGENESIS 40 364 1.748e-05 0.0002894
282 EYE DEVELOPMENT 37 326 1.759e-05 0.0002903
283 CELL PART MORPHOGENESIS 60 633 1.784e-05 0.0002923
284 REGULATION OF PHOSPHATASE ACTIVITY 20 128 1.784e-05 0.0002923
285 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 34 289 1.804e-05 0.0002946
286 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 39 352 1.839e-05 0.0002991
287 POSITIVE REGULATION OF STEM CELL PROLIFERATION 13 61 1.853e-05 3e-04
288 REGULATION OF GENE EXPRESSION EPIGENETIC 29 229 1.857e-05 3e-04
289 NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 17 98 1.869e-05 0.0003009
290 REGULATION OF CELL CYCLE ARREST 18 108 1.891e-05 0.0003034
291 NEURAL PRECURSOR CELL PROLIFERATION 14 70 1.923e-05 0.0003075
292 REGULATION OF MUSCLE SYSTEM PROCESS 26 195 2.009e-05 0.0003202
293 REGULATION OF MICROTUBULE BASED PROCESS 30 243 2.203e-05 0.0003499
294 ESTABLISHMENT OF PROTEIN LOCALIZATION 113 1423 2.248e-05 0.0003557
295 MIDBRAIN DEVELOPMENT 16 90 2.381e-05 0.0003756
296 REGULATION OF CHROMATIN ORGANIZATION 22 152 2.391e-05 0.0003759
297 ANGIOGENESIS 34 293 2.406e-05 0.0003769
298 RESPONSE TO GROWTH FACTOR 48 475 2.467e-05 0.0003852
299 INOSITOL PHOSPHATE MEDIATED SIGNALING 7 18 2.514e-05 0.0003913
300 NEGATIVE REGULATION OF BINDING 20 131 2.525e-05 0.0003916
301 PEPTIDYL THREONINE MODIFICATION 11 46 2.583e-05 0.0003994
302 FC EPSILON RECEPTOR SIGNALING PATHWAY 21 142 2.616e-05 0.0004031
303 COVALENT CHROMATIN MODIFICATION 38 345 2.671e-05 0.0004102
304 POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 31 258 2.764e-05 0.0004216
305 CELL CYCLE G1 S PHASE TRANSITION 18 111 2.773e-05 0.0004216
306 G1 S TRANSITION OF MITOTIC CELL CYCLE 18 111 2.773e-05 0.0004216
307 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 57 602 2.968e-05 0.0004498
308 PANCREAS DEVELOPMENT 14 73 3.162e-05 0.0004761
309 CELLULAR RESPONSE TO KETONE 14 73 3.162e-05 0.0004761
310 RESPONSE TO RADIATION 43 413 3.196e-05 0.0004797
311 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 76 876 3.214e-05 0.0004809
312 RESPONSE TO ALCOHOL 39 362 3.463e-05 0.0005165
313 PATTERNING OF BLOOD VESSELS 9 32 3.502e-05 0.0005184
314 IN UTERO EMBRYONIC DEVELOPMENT 35 311 3.509e-05 0.0005184
315 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA 9 32 3.502e-05 0.0005184
316 OUTFLOW TRACT MORPHOGENESIS 12 56 3.647e-05 0.0005371
317 REGULATION OF APOPTOTIC SIGNALING PATHWAY 39 363 3.683e-05 0.0005406
318 NEGATIVE REGULATION OF AXONOGENESIS 13 65 3.79e-05 0.0005545
319 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 47 470 3.882e-05 0.0005663
320 DIGESTIVE TRACT MORPHOGENESIS 11 48 3.961e-05 0.000576
321 REGULATION OF CHEMOTAXIS 24 180 4.129e-05 0.0005986
322 KIDNEY EPITHELIUM DEVELOPMENT 19 125 4.248e-05 0.0006139
323 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 102 1275 4.303e-05 0.0006199
324 CELLULAR RESPONSE TO UV 13 66 4.488e-05 0.0006425
325 LENS DEVELOPMENT IN CAMERA TYPE EYE 13 66 4.488e-05 0.0006425
326 PALATE DEVELOPMENT 15 85 4.643e-05 0.0006607
327 POSITIVE REGULATION OF CELL CYCLE ARREST 15 85 4.643e-05 0.0006607
328 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 34 303 4.79e-05 0.0006795
329 NEGATIVE REGULATION OF CELL DEATH 75 872 4.816e-05 0.0006811
330 POSITIVE REGULATION OF CELL GROWTH 21 148 4.898e-05 0.0006906
331 RESPONSE TO ORGANIC CYCLIC COMPOUND 78 917 4.944e-05 0.000695
332 PROSTATE GLAND DEVELOPMENT 10 41 5.003e-05 0.0007012
333 REGULATION OF HYDROLASE ACTIVITY 105 1327 5.142e-05 0.0007185
334 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 13 67 5.295e-05 0.0007377
335 NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION 16 96 5.415e-05 0.0007522
336 TRACHEA DEVELOPMENT 7 20 5.566e-05 0.0007708
337 REGULATION OF BMP SIGNALING PATHWAY 14 77 5.87e-05 0.0008104
338 RESPONSE TO RETINOIC ACID 17 107 5.997e-05 0.0008255
339 ORGAN GROWTH 13 68 6.226e-05 0.0008521
340 POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION 13 68 6.226e-05 0.0008521
341 PROTEASOMAL PROTEIN CATABOLIC PROCESS 31 271 7.092e-05 0.0009677
342 POSITIVE REGULATION OF FAT CELL DIFFERENTIATION 11 51 7.193e-05 0.0009759
343 MICROTUBULE CYTOSKELETON ORGANIZATION 37 348 7.194e-05 0.0009759
344 RESPONSE TO MECHANICAL STIMULUS 26 210 7.233e-05 0.0009784
345 NEGATIVE REGULATION OF CELL DIVISION 12 60 7.484e-05 0.001006
346 CHONDROCYTE DIFFERENTIATION 12 60 7.484e-05 0.001006
347 BONE MORPHOGENESIS 14 79 7.861e-05 0.001054
348 LIPID METABOLIC PROCESS 93 1158 8.223e-05 0.001099
349 POSITIVE REGULATION OF PHOSPHATASE ACTIVITY 8 28 8.468e-05 0.001129
350 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 16 100 8.983e-05 0.001194
351 NEGATIVE REGULATION OF LIPID METABOLIC PROCESS 14 80 9.06e-05 0.001201
352 REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 9 36 9.666e-05 0.001278
353 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 24 190 9.857e-05 0.001299
354 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 18 122 9.948e-05 0.001304
355 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 20 144 9.942e-05 0.001304
356 MAMMARY GLAND EPITHELIUM DEVELOPMENT 11 53 0.0001042 0.001359
357 REGULATION OF FIBROBLAST PROLIFERATION 14 81 0.0001041 0.001359
358 POSITIVE REGULATION OF MITOTIC CELL CYCLE 18 123 0.0001107 0.001428
359 STEM CELL DIVISION 8 29 0.0001114 0.001428
360 POSITIVE REGULATION OF MUSCLE HYPERTROPHY 7 22 0.0001113 0.001428
361 SOMATIC STEM CELL DIVISION 7 22 0.0001113 0.001428
362 POSITIVE REGULATION OF CARDIAC MUSCLE HYPERTROPHY 7 22 0.0001113 0.001428
363 STEROL METABOLIC PROCESS 18 123 0.0001107 0.001428
364 POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 27 228 0.0001138 0.00145
365 TELENCEPHALON DEVELOPMENT 27 228 0.0001138 0.00145
366 GLYCEROLIPID METABOLIC PROCESS 37 356 0.0001151 0.001464
367 ENDOCHONDRAL BONE MORPHOGENESIS 10 45 0.0001169 0.001482
368 REGULATION OF MUSCLE HYPERTROPHY 9 37 0.0001216 0.001538
369 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 19 135 0.000123 0.001551
370 CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT 6 16 0.0001245 0.001565
371 CELLULAR MACROMOLECULE LOCALIZATION 97 1234 0.0001275 0.0016
372 REGULATION OF MUSCLE TISSUE DEVELOPMENT 16 103 0.0001287 0.001606
373 REGULATION OF MUSCLE ORGAN DEVELOPMENT 16 103 0.0001287 0.001606
374 G1 DNA DAMAGE CHECKPOINT 13 73 0.0001332 0.001658
375 RESPONSE TO KETONE 23 182 0.0001355 0.001682
376 LOCOMOTION 89 1114 0.0001403 0.001736
377 NEGATIVE REGULATION OF DNA BINDING 10 46 0.0001422 0.001755
378 RESPONSE TO LIPID 74 888 0.000146 0.001797
379 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 25 207 0.0001472 0.001807
380 MESENCHYME MORPHOGENESIS 9 38 0.0001518 0.001859
381 PLACENTA DEVELOPMENT 19 138 0.0001651 0.002017
382 THYMUS DEVELOPMENT 10 47 0.0001719 0.002094
383 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 24 197 0.0001732 0.002105
384 REGULATION OF HISTONE METHYLATION 11 56 0.0001755 0.002121
385 CHROMATIN REMODELING 20 150 0.0001753 0.002121
386 NEURAL CREST CELL DIFFERENTIATION 13 75 0.0001769 0.002132
387 CARDIAC SEPTUM DEVELOPMENT 14 85 0.0001775 0.002134
388 REGULATION OF CELL ADHESION 56 629 0.0001804 0.002164
389 REGULATION OF CHROMATIN BINDING 6 17 0.0001836 0.00219
390 NEGATIVE REGULATION OF GLUCOSE TRANSPORT 6 17 0.0001836 0.00219
391 HEPATICOBILIARY SYSTEM DEVELOPMENT 18 128 0.0001856 0.002208
392 EPITHELIAL CELL DEVELOPMENT 23 186 0.0001879 0.002225
393 COCHLEA DEVELOPMENT 9 39 0.0001879 0.002225
394 CYTOSKELETON ORGANIZATION 70 838 0.0002048 0.002419
395 REGULATION OF PROTEIN PHOSPHATASE TYPE 2A ACTIVITY 7 24 0.0002054 0.002419
396 REGULATION OF DNA METABOLIC PROCESS 35 340 0.0002095 0.002462
397 REGULATION OF HORMONE SECRETION 29 262 0.0002121 0.002485
398 CELLULAR RESPONSE TO ABIOTIC STIMULUS 29 263 0.0002263 0.002646
399 ENDOCRINE PANCREAS DEVELOPMENT 9 40 0.000231 0.002693
400 POSITIVE REGULATION OF GROWTH 27 238 0.0002319 0.002698
401 OSSIFICATION 28 251 0.0002376 0.002757
402 EMBRYONIC PATTERN SPECIFICATION 11 58 0.0002431 0.002813
403 NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS 18 131 0.0002491 0.002876
404 REGULATION OF DENDRITE DEVELOPMENT 17 120 0.0002534 0.002918
405 REGULATION OF CELL JUNCTION ASSEMBLY 12 68 0.0002614 0.003003
406 POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION 5 12 0.0002653 0.003004
407 CARTILAGE MORPHOGENESIS 5 12 0.0002653 0.003004
408 POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION 6 18 0.0002628 0.003004
409 TRACHEA MORPHOGENESIS 5 12 0.0002653 0.003004
410 PERICARDIUM DEVELOPMENT 6 18 0.0002628 0.003004
411 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 5 12 0.0002653 0.003004
412 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM 7 25 0.000272 0.003072
413 FORMATION OF PRIMARY GERM LAYER 16 110 0.0002807 0.003163
414 REGULATION OF RESPONSE TO STRESS 110 1468 0.0002913 0.003274
415 REGULATION OF ADHERENS JUNCTION ORGANIZATION 10 50 0.0002943 0.0033
416 POSITIVE REGULATION OF HISTONE METHYLATION 8 33 0.0002972 0.003324
417 BONE DEVELOPMENT 20 156 0.0002982 0.003327
418 DENDRITE DEVELOPMENT 13 79 0.0003019 0.00336
419 REGULATION OF PROTEIN BINDING 21 168 0.0003027 0.003361
420 NEGATIVE REGULATION OF CELL PROLIFERATION 56 643 0.0003147 0.003487
421 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 47 514 0.0003221 0.00356
422 ALCOHOL METABOLIC PROCESS 35 348 0.0003257 0.003591
423 CALCIUM MEDIATED SIGNALING 14 90 0.0003283 0.003595
424 NEGATIVE REGULATION OF TRANSPORT 43 458 0.0003275 0.003595
425 REGULATION OF CELL MATRIX ADHESION 14 90 0.0003283 0.003595
426 REGULATION OF DEPHOSPHORYLATION 20 158 0.0003532 0.003858
427 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 26 232 0.0003633 0.003958
428 REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 6 19 0.0003665 0.003976
429 POSITIVE REGULATION OF MAP KINASE ACTIVITY 24 207 0.0003658 0.003976
430 DORSAL VENTRAL PATTERN FORMATION 14 91 0.000369 0.003989
431 NEGATIVE REGULATION OF MITOTIC NUCLEAR DIVISION 8 34 0.0003703 0.003989
432 BRAIN MORPHOGENESIS 8 34 0.0003703 0.003989
433 REGULATION OF CELLULAR COMPONENT SIZE 34 337 0.0003718 0.003996
434 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 15 102 0.0003816 0.004091
435 EMBRYONIC DIGIT MORPHOGENESIS 11 61 0.0003848 0.004116
436 PEPTIDYL SERINE MODIFICATION 19 148 0.0004106 0.004366
437 REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 9 43 0.0004116 0.004366
438 REGULATION OF CELL FATE SPECIFICATION 5 13 0.0004119 0.004366
439 GANGLION DEVELOPMENT 5 13 0.0004119 0.004366
440 POSITIVE REGULATION OF HYDROLASE ACTIVITY 73 905 0.0004215 0.004437
441 REGULATION OF CALCIUM ION TRANSPORT 24 209 0.0004215 0.004437
442 REGULATION OF PEPTIDE SECRETION 24 209 0.0004215 0.004437
443 REGULATION OF CIRCADIAN RHYTHM 15 103 0.0004247 0.004451
444 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 15 103 0.0004247 0.004451
445 REGULATION OF HORMONE LEVELS 44 478 0.0004286 0.004481
446 KIDNEY MORPHOGENESIS 13 82 0.0004392 0.004582
447 ENDOTHELIAL CELL DIFFERENTIATION 12 72 0.0004519 0.004688
448 REGULATION OF CELL SUBSTRATE ADHESION 21 173 0.0004513 0.004688
449 REGULATION OF DNA REPLICATION 20 161 0.0004524 0.004688
450 MICROTUBULE BASED PROCESS 47 522 0.0004537 0.004691
451 DEVELOPMENTAL INDUCTION 7 27 0.0004569 0.004693
452 NEGATIVE REGULATION OF AXON GUIDANCE 7 27 0.0004569 0.004693
453 REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY 7 27 0.0004569 0.004693
454 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 14 93 0.0004635 0.00475
455 POSITIVE REGULATION OF PROTEIN IMPORT 15 104 0.0004719 0.004826
456 CELL CYCLE G2 M PHASE TRANSITION 18 138 0.0004752 0.004849
457 POSITIVE REGULATION OF FIBROBLAST PROLIFERATION 10 53 0.0004822 0.00491
458 ORGAN REGENERATION 13 83 0.0004954 0.005033
459 RELAXATION OF MUSCLE 6 20 0.0004998 0.005034
460 POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS 6 20 0.0004998 0.005034
461 SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 17 127 0.0004989 0.005034
462 BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS 6 20 0.0004998 0.005034
463 MUSCLE CELL DIFFERENTIATION 26 237 0.0005046 0.005071
464 CELL MOTILITY 68 835 0.0005085 0.005089
465 LOCALIZATION OF CELL 68 835 0.0005085 0.005089
466 REGULATION OF EPIDERMIS DEVELOPMENT 11 63 0.0005134 0.005126
467 REGULATION OF NUCLEAR DIVISION 20 163 0.0005312 0.005293
468 SMALL MOLECULE METABOLIC PROCESS 127 1767 0.00054 0.005368
469 CELLULAR LIPID METABOLIC PROCESS 73 913 0.0005411 0.005368
470 CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS 22 188 0.0005556 0.005501
471 POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY 8 36 0.0005606 0.005526
472 POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 8 36 0.0005606 0.005526
473 VENTRICULAR SEPTUM DEVELOPMENT 10 54 0.0005635 0.005543
474 VENTRICULAR SEPTUM MORPHOGENESIS 7 28 0.000581 0.005691
475 INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 15 106 0.0005799 0.005691
476 LUNG MORPHOGENESIS 9 45 0.0005869 0.005701
477 THYMOCYTE AGGREGATION 9 45 0.0005869 0.005701
478 SPROUTING ANGIOGENESIS 9 45 0.0005869 0.005701
479 T CELL DIFFERENTIATION IN THYMUS 9 45 0.0005869 0.005701
480 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 17 129 0.0005988 0.005805
481 REGULATION OF MAP KINASE ACTIVITY 32 319 0.0006017 0.005821
482 RESPONSE TO EXTERNAL STIMULUS 130 1821 0.0006053 0.005843
483 REGULATION OF ANATOMICAL STRUCTURE SIZE 43 472 0.0006131 0.005882
484 POSITIVE REGULATION OF CELL SIZE 5 14 0.0006123 0.005882
485 NEGATIVE REGULATION OF GLUCOSE IMPORT 5 14 0.0006123 0.005882
486 POSITIVE REGULATION OF NEURON DIFFERENTIATION 31 306 0.0006163 0.005901
487 ESTABLISHMENT OF LOCALIZATION IN CELL 121 1676 0.0006208 0.005931
488 PALLIUM DEVELOPMENT 19 153 0.0006236 0.005946
489 MESODERM DEVELOPMENT 16 118 0.0006251 0.005948
490 RESPONSE TO LIGHT STIMULUS 29 280 0.0006392 0.00607
491 SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE 14 96 0.0006434 0.006097
492 PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL 70 873 0.0006477 0.006126
493 APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT 6 21 0.0006679 0.006291
494 POSITIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION 6 21 0.0006679 0.006291
495 REGULATION OF EPITHELIAL CELL MIGRATION 20 166 0.0006717 0.006314
496 NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 8 37 0.0006817 0.006395
497 RESPONSE TO PEPTIDE 38 404 0.0006853 0.006403
498 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 38 404 0.0006853 0.006403
499 NEGATIVE REGULATION OF NUCLEAR DIVISION 9 46 0.000695 0.006481
500 GLAND MORPHOGENESIS 14 97 0.0007151 0.006642
501 REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 14 97 0.0007151 0.006642
502 NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS 7 29 0.0007304 0.00677
503 REGULATION OF PEPTIDE TRANSPORT 27 256 0.0007335 0.006786
504 IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 32 323 0.000744 0.006869
505 REGULATION OF CALCIUM MEDIATED SIGNALING 12 76 0.0007482 0.006893
506 POSITIVE REGULATION OF LOCOMOTION 39 420 0.0007507 0.006901
507 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 38 406 0.0007519 0.006901
508 PROTEIN CATABOLIC PROCESS 50 579 0.00078 0.007136
509 MAINTENANCE OF CELL NUMBER 17 132 0.0007806 0.007136
510 REGULATION OF FATTY ACID METABOLIC PROCESS 13 87 0.000785 0.007162
511 CARDIAC CHAMBER DEVELOPMENT 18 144 0.0007929 0.007212
512 RESPONSE TO VITAMIN 14 98 0.0007936 0.007212
513 FC RECEPTOR SIGNALING PATHWAY 23 206 0.0008137 0.00738
514 POSITIVE REGULATION OF DEPHOSPHORYLATION 9 47 0.0008189 0.007413
515 NEGATIVE REGULATION OF AXON EXTENSION 8 38 0.000823 0.007421
516 REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 8 38 0.000823 0.007421
517 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 16 121 0.0008254 0.007428
518 REGULATION OF CELL DIVISION 28 272 0.0008636 0.007757
519 REGULATION OF MESODERM DEVELOPMENT 5 15 0.0008777 0.007839
520 MODULATION OF TRANSCRIPTION IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 6 22 0.0008766 0.007839
521 RESPONSE TO VITAMIN E 5 15 0.0008777 0.007839
522 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 16 122 0.0009032 0.008036
523 LIPID BIOSYNTHETIC PROCESS 47 539 0.0009029 0.008036
524 NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 7 30 0.0009087 0.008069
525 ORGANIC HYDROXY COMPOUND METABOLIC PROCESS 43 482 0.0009356 0.008292
526 REGULATION OF GTPASE ACTIVITY 56 673 0.0009427 0.008339
527 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 9 48 0.0009602 0.008462
528 RESPONSE TO STEROID HORMONE 44 497 0.0009584 0.008462
529 PROTEIN UBIQUITINATION 53 629 0.000965 0.008488
530 POSITIVE REGULATION OF VIRAL TRANSCRIPTION 8 39 0.0009868 0.008664
531 REGULATION OF CELLULAR COMPONENT BIOGENESIS 62 767 0.001063 0.009309
532 NEGATIVE REGULATION OF PROTEIN BINDING 12 79 0.001064 0.009309
533 MONOCARBOXYLIC ACID TRANSPORT 16 124 0.001078 0.009409
534 MESONEPHROS DEVELOPMENT 13 90 0.001086 0.00946
535 NEGATIVE REGULATION OF LOCOMOTION 27 263 0.001102 0.009585
536 REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING 6 23 0.001132 0.009773
537 REGULATION OF CELLULAR KETONE METABOLIC PROCESS 20 173 0.001129 0.009773
538 STEROID METABOLIC PROCESS 25 237 0.001129 0.009773
539 SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 6 23 0.001132 0.009773
540 CELL DEATH 77 1001 0.001162 0.009998
541 REGENERATION 19 161 0.001162 0.009998
NumGOOverlapSizeP ValueAdj. P Value
1 BETA CATENIN BINDING 29 84 2.182e-16 1.251e-13
2 WNT ACTIVATED RECEPTOR ACTIVITY 16 22 2.694e-16 1.251e-13
3 WNT PROTEIN BINDING 18 31 1.474e-15 4.564e-13
4 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 52 315 5.488e-13 1.275e-10
5 FRIZZLED BINDING 17 36 8.464e-13 1.573e-10
6 ENZYME BINDING 163 1737 1.284e-12 1.989e-10
7 REGULATORY REGION NUCLEIC ACID BINDING 94 818 3.132e-12 4.156e-10
8 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 48 328 3.265e-10 3.791e-08
9 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 38 226 4.313e-10 4.452e-08
10 PROTEIN SERINE THREONINE KINASE ACTIVITY 58 445 4.908e-10 4.559e-08
11 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 72 629 1.449e-09 1.224e-07
12 DOUBLE STRANDED DNA BINDING 82 764 2.231e-09 1.727e-07
13 TRANSCRIPTION FACTOR BINDING 62 524 5.853e-09 3.625e-07
14 PROTEIN DOMAIN SPECIFIC BINDING 70 624 5.749e-09 3.625e-07
15 SEQUENCE SPECIFIC DNA BINDING 101 1037 5.722e-09 3.625e-07
16 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 112 1199 8.362e-09 4.855e-07
17 RIBONUCLEOTIDE BINDING 153 1860 7.619e-08 4.164e-06
18 ADENYL NUCLEOTIDE BINDING 129 1514 1.352e-07 6.975e-06
19 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 63 588 1.809e-07 8.845e-06
20 CORE PROMOTER PROXIMAL REGION DNA BINDING 45 371 3.581e-07 1.664e-05
21 KINASE ACTIVITY 80 842 6.519e-07 2.754e-05
22 GTPASE BINDING 38 295 6.521e-07 2.754e-05
23 PROTEIN DIMERIZATION ACTIVITY 100 1149 1.539e-06 6.037e-05
24 PROTEIN KINASE ACTIVITY 64 640 1.625e-06 6.037e-05
25 IDENTICAL PROTEIN BINDING 104 1209 1.603e-06 6.037e-05
26 TRANSCRIPTION COACTIVATOR ACTIVITY 36 296 4.886e-06 0.0001746
27 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 87 992 5.644e-06 0.0001942
28 KINASE BINDING 58 606 1.853e-05 0.0006149
29 CORE PROMOTER BINDING 22 152 2.391e-05 0.000766
30 SMAD BINDING 14 72 2.688e-05 0.0008322
31 ARMADILLO REPEAT DOMAIN BINDING 6 13 3.07e-05 0.00092
32 RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 17 104 4.135e-05 0.001201
33 ZINC ION BINDING 94 1155 4.601e-05 0.001295
34 PROTEIN HOMODIMERIZATION ACTIVITY 64 722 7.246e-05 0.001946
35 G PROTEIN COUPLED RECEPTOR BINDING 30 259 7.332e-05 0.001946
36 UBIQUITIN LIKE PROTEIN TRANSFERASE ACTIVITY 42 420 9.844e-05 0.00254
37 CHROMATIN BINDING 43 435 0.0001062 0.002666
38 RECEPTOR AGONIST ACTIVITY 6 16 0.0001245 0.003043
39 R SMAD BINDING 7 23 0.0001526 0.003634
40 I SMAD BINDING 5 11 0.000162 0.003756
41 MOLECULAR FUNCTION REGULATOR 104 1353 0.0001698 0.003756
42 TRANSITION METAL ION BINDING 107 1400 0.0001696 0.003756
43 P53 BINDING 12 67 0.0002262 0.004887
44 RECEPTOR ACTIVATOR ACTIVITY 8 32 0.0002362 0.004984
45 UBIQUITIN LIKE PROTEIN LIGASE BINDING 29 264 0.0002414 0.004984
46 MACROMOLECULAR COMPLEX BINDING 106 1399 0.0002513 0.005075
47 RHO GTPASE BINDING 13 78 0.0002651 0.005241
48 OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS 18 134 0.0003308 0.006402
49 TRANSLATION REGULATOR ACTIVITY 8 35 0.0004575 0.008673
50 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II ACTIVATING TRANSCRIPTION FACTOR BINDING 10 53 0.0004822 0.00896
51 PROTEIN HETERODIMERIZATION ACTIVITY 43 468 0.0005148 0.009377
NumGOOverlapSizeP ValueAdj. P Value
1 BETA CATENIN DESTRUCTION COMPLEX 11 14 3.5e-12 1.022e-09
2 WNT SIGNALOSOME 10 11 2.18e-12 1.022e-09
3 ENDOCYTIC VESICLE 35 256 4.352e-07 8.472e-05
4 ENDOCYTIC VESICLE MEMBRANE 25 152 6.296e-07 9.192e-05
5 MICROTUBULE CYTOSKELETON 95 1068 1.119e-06 9.333e-05
6 EXCITATORY SYNAPSE 29 197 9.079e-07 9.333e-05
7 SYNAPSE 73 754 1.019e-06 9.333e-05
8 CATALYTIC COMPLEX 92 1038 1.939e-06 0.0001415
9 TRANSCRIPTION FACTOR COMPLEX 36 298 5.697e-06 0.0003697
10 PHOSPHATASE COMPLEX 12 48 6.794e-06 0.0003968
11 CHROMATIN 47 441 7.547e-06 0.0004007
12 CHROMOSOME 78 880 1.197e-05 0.000581
13 PCG PROTEIN COMPLEX 11 43 1.293e-05 0.000581
14 NEURONAL POSTSYNAPTIC DENSITY 12 53 2.025e-05 0.0007884
15 LAMELLIPODIUM 24 172 1.938e-05 0.0007884
16 CENTROSOME 49 487 2.281e-05 0.0008324
17 PERINUCLEAR REGION OF CYTOPLASM 60 642 2.706e-05 0.0009298
18 TRANSFERASE COMPLEX 64 703 3.286e-05 0.001066
19 CELL PROJECTION 135 1786 3.818e-05 0.001174
20 MICROTUBULE ORGANIZING CENTER 58 623 4.096e-05 0.001196
21 PROTEIN PHOSPHATASE TYPE 2A COMPLEX 7 20 5.566e-05 0.001548
22 LATERAL PLASMA MEMBRANE 11 50 5.929e-05 0.001574
23 VESICLE MEMBRANE 49 512 8.126e-05 0.00176
24 CYTOSKELETAL PART 111 1436 8.135e-05 0.00176
25 COATED VESICLE 28 234 7.139e-05 0.00176
26 CELL LEADING EDGE 37 350 8.107e-05 0.00176
27 SYNAPSE PART 56 610 8.078e-05 0.00176
28 POSTSYNAPSE 39 378 8.911e-05 0.001859
29 CLATHRIN COATED VESICLE 21 157 0.0001166 0.002348
30 NEURON PART 98 1265 0.0001991 0.003875
31 MEMBRANE MICRODOMAIN 31 288 0.0002159 0.00394
32 ENDOPLASMIC RETICULUM 121 1631 0.000215 0.00394
33 CELL PROJECTION PART 77 946 0.0002241 0.003967
34 NUCLEAR CHROMATIN 31 291 0.0002594 0.004329
35 MEMBRANE REGION 89 1134 0.0002555 0.004329
36 APICAL PART OF CELL 36 361 0.0003173 0.005147
37 SCF UBIQUITIN LIGASE COMPLEX 8 34 0.0003703 0.005845
38 EARLY ENDOSOME MEMBRANE 16 113 0.0003831 0.005887
39 INTRACELLULAR VESICLE 96 1259 0.0003988 0.005973
40 CYTOSKELETON 140 1967 0.0004186 0.006111
41 NUCLEAR CHROMOSOME 47 523 0.0004731 0.006578
42 EARLY ENDOSOME 31 301 0.0004663 0.006578
43 CHROMOSOME CENTROMERIC REGION 21 174 0.0004876 0.006623
44 NEURON PROJECTION 75 942 0.0005151 0.006836
45 GOLGI APPARATUS 107 1445 0.0005398 0.007006
46 CYTOPLASMIC VESICLE PART 52 601 0.0005915 0.007509
47 NUCLEAR ENVELOPE 39 416 0.000625 0.007766
48 CLATHRIN COATED ENDOCYTIC VESICLE 11 65 0.0006761 0.008226
49 MICROTUBULE 38 405 0.0007179 0.008556

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 Wnt_signaling_pathway_hsa04310 109 146 4.157e-107 2.162e-105
2 Hippo_signaling_pathway_hsa04390 57 154 8.096e-33 2.105e-31
3 Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 40 139 7.839e-19 1.359e-17
4 Oocyte_meiosis_hsa04114 32 124 7.169e-14 9.319e-13
5 mTOR_signaling_pathway_hsa04150 34 151 8.559e-13 8.901e-12
6 Cell_cycle_hsa04110 29 124 1.505e-11 1.305e-10
7 Cellular_senescence_hsa04218 33 160 2.363e-11 1.756e-10
8 Adherens_junction_hsa04520 21 72 1.154e-10 7.5e-10
9 p53_signaling_pathway_hsa04115 18 68 1.348e-08 7.786e-08
10 FoxO_signaling_pathway_hsa04068 25 132 3.726e-08 1.938e-07
11 TGF_beta_signaling_pathway_hsa04350 19 84 8.541e-08 4.037e-07
12 cAMP_signaling_pathway_hsa04024 30 198 3.144e-07 1.362e-06
13 Focal_adhesion_hsa04510 30 199 3.514e-07 1.406e-06
14 Sphingolipid_signaling_pathway_hsa04071 21 118 1.317e-06 4.893e-06
15 Tight_junction_hsa04530 26 170 1.582e-06 5.484e-06
16 ErbB_signaling_pathway_hsa04012 16 85 1.126e-05 3.658e-05
17 Phosphatidylinositol_signaling_system_hsa04070 17 99 2.144e-05 6.558e-05
18 AMPK_signaling_pathway_hsa04152 19 121 2.673e-05 7.721e-05
19 Hedgehog_signaling_pathway_hsa04340 11 47 3.209e-05 8.783e-05
20 VEGF_signaling_pathway_hsa04370 12 59 6.294e-05 0.0001636
21 cGMP_PKG_signaling_pathway_hsa04022 22 163 7.069e-05 0.000175
22 Calcium_signaling_pathway_hsa04020 22 182 0.0003542 0.0008373
23 MAPK_signaling_pathway_hsa04010 30 295 0.0007031 0.00159
24 Apelin_signaling_pathway_hsa04371 17 137 0.001188 0.002575
25 PI3K_Akt_signaling_pathway_hsa04151 33 352 0.001578 0.003281
26 Regulation_of_actin_cytoskeleton_hsa04810 22 208 0.0021 0.004199
27 HIF_1_signaling_pathway_hsa04066 13 100 0.002858 0.005504
28 Notch_signaling_pathway_hsa04330 8 48 0.003937 0.007312
29 Gap_junction_hsa04540 11 88 0.007829 0.01398
30 Mitophagy_animal_hsa04137 9 65 0.008067 0.01398
31 ABC_transporters_hsa02010 7 45 0.01001 0.01679
32 Rap1_signaling_pathway_hsa04015 19 206 0.01662 0.027
33 Hippo_signaling_pathway_multiple_species_hsa04392 5 29 0.01852 0.02918
34 Autophagy_animal_hsa04140 13 128 0.02144 0.03278
35 Ras_signaling_pathway_hsa04014 20 232 0.02737 0.04066
36 Apoptosis_multiple_species_hsa04215 5 33 0.03101 0.04479
37 Apoptosis_hsa04210 12 138 0.07131 0.09811
38 Endocytosis_hsa04144 19 244 0.0717 0.09811
39 ECM_receptor_interaction_hsa04512 7 82 0.1554 0.2072
40 Peroxisome_hsa04146 7 83 0.1624 0.2095
41 Phospholipase_D_signaling_pathway_hsa04072 11 146 0.1684 0.2095
42 Ferroptosis_hsa04216 4 40 0.1692 0.2095
43 Lysosome_hsa04142 9 123 0.2226 0.2692
44 NF_kappa_B_signaling_pathway_hsa04064 7 95 0.2552 0.3016
45 Necroptosis_hsa04217 11 164 0.2756 0.3185
46 TNF_signaling_pathway_hsa04668 7 108 0.3685 0.4166
47 Autophagy_other_hsa04136 2 32 0.5233 0.5741
48 Cell_adhesion_molecules_.CAMs._hsa04514 8 145 0.53 0.5741
49 Jak_STAT_signaling_pathway_hsa04630 8 162 0.6557 0.6959
50 Phagosome_hsa04145 4 152 0.9677 1
51 Cytokine_cytokine_receptor_interaction_hsa04060 5 270 0.9991 1

lncRNA-mediated sponge

(Download full result)

Num lncRNA miRNAs           miRNAs count     Gene Sponge regulatory network lncRNA log2FC lncRNA pvalue Gene log2FC Gene pvalue lncRNA-gene Pearson correlation
1 LDLRAD4-AS1 hsa-miR-106b-5p;hsa-miR-132-3p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-3127-5p;hsa-miR-454-3p;hsa-miR-589-3p 10 FZD4 Sponge network -3.366 0 -0.346 0.01097 0.404
2 AC005550.3 hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-183-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-362-3p;hsa-miR-92a-3p;hsa-miR-92b-3p 10 DAAM1 Sponge network -2.571 0.00132 -0.82 3.0E-5 0.394
3

RP11-166D19.1

 hsa-miR-106b-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-32-3p;hsa-miR-32-5p;hsa-miR-324-3p;hsa-miR-330-5p;hsa-miR-361-5p;hsa-miR-484;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-629-3p;hsa-miR-92a-3p;hsa-miR-940 18 FZD4 Sponge network -0.244 0.28835 -0.346 0.01097 0.384
4

MAGI2-AS3

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-1266-5p;hsa-miR-15b-5p;hsa-miR-17-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-425-5p;hsa-miR-589-3p;hsa-miR-616-5p;hsa-miR-9-5p;hsa-miR-92a-3p;hsa-miR-93-5p 16 CCND1 Sponge network -1.801 0 -0.902 1.0E-5 0.359
5 RP11-12A2.3 hsa-let-7d-5p;hsa-miR-106b-5p;hsa-miR-132-3p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-330-5p;hsa-miR-92a-3p 11 FZD4 Sponge network -4.779 0 -0.346 0.01097 0.342
6 RP11-7F17.3 hsa-let-7d-5p;hsa-miR-106b-5p;hsa-miR-132-3p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-3127-5p;hsa-miR-324-3p;hsa-miR-330-5p;hsa-miR-940 12 FZD4 Sponge network -0.873 0.00204 -0.346 0.01097 0.341
7 RP11-480I12.7 hsa-miR-142-5p;hsa-miR-146a-5p;hsa-miR-150-5p;hsa-miR-218-5p;hsa-miR-22-5p;hsa-miR-2355-3p;hsa-miR-24-2-5p;hsa-miR-330-3p;hsa-miR-381-3p;hsa-miR-495-3p 10 PRKCA Sponge network 2.03 0 0.663 0 0.332
8 MIR497HG hsa-miR-106b-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-185-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-32-3p;hsa-miR-324-3p;hsa-miR-589-3p;hsa-miR-940 11 FZD4 Sponge network -0.886 0.00689 -0.346 0.01097 0.313
9 TOB1-AS1 hsa-miR-142-5p;hsa-miR-146a-5p;hsa-miR-150-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-218-5p;hsa-miR-2355-3p;hsa-miR-330-3p;hsa-miR-450b-5p 10 PRKCA Sponge network 0.811 0 0.663 0 0.308
10 LINC00261 hsa-miR-106b-5p;hsa-miR-132-3p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-3127-5p;hsa-miR-324-3p;hsa-miR-330-5p;hsa-miR-454-3p;hsa-miR-589-3p;hsa-miR-629-3p;hsa-miR-940 11 FZD4 Sponge network -1.194 0 -0.346 0.01097 0.3
11 CASC2 hsa-miR-107;hsa-miR-148b-3p;hsa-miR-17-3p;hsa-miR-192-3p;hsa-miR-193a-3p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-21-5p;hsa-miR-362-5p;hsa-miR-548j-5p;hsa-miR-885-5p 11 NFAT5 Sponge network -0.596 0.00187 -0.326 0.00164 0.281
12 RP11-539I5.1 hsa-miR-107;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-194-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-30b-3p;hsa-miR-30d-5p;hsa-miR-30e-5p;hsa-miR-32-3p 11 FZD3 Sponge network -1.111 0.02467 -0.432 0.07605 0.259
13 SMIM2-AS1 hsa-let-7d-5p;hsa-miR-106b-5p;hsa-miR-132-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-3127-5p;hsa-miR-330-5p;hsa-miR-589-3p;hsa-miR-629-3p;hsa-miR-940;hsa-miR-98-5p 13 FZD4 Sponge network -0.66 0.00587 -0.346 0.01097 0.253
14

RP11-166D19.1

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-1266-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-425-5p;hsa-miR-589-3p;hsa-miR-616-5p;hsa-miR-92a-3p;hsa-miR-942-5p 17 CCND1 Sponge network -0.244 0.28835 -0.902 1.0E-5 0.253

Quest ID: 9316367811f63b732ae123c4d60219cc